Drug Shortage Report for ZANTAC
Report ID | 2751 |
Drug Identification Number | 02212366 |
Brand name | ZANTAC |
Common or Proper name | Ranitidine injection |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 2mL x 10's |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2016-04-25 |
Estimated end date | |
Actual end date | 2018-08-31 |
Shortage status | Resolved |
Updated date | 2020-02-27 |
Company comments | This product has been discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2020-02-27 | French | Compare |
v13 | 2020-02-27 | English | Compare |
v12 | 2017-09-18 | French | Compare |
v11 | 2017-09-18 | English | Compare |
v10 | 2017-04-05 | French | Compare |
v9 | 2017-04-05 | English | Compare |
v8 | 2017-03-24 | French | Compare |
v7 | 2017-03-24 | French | Compare |
v6 | 2017-03-24 | English | Compare |
v5 | 2017-03-24 | English | Compare |
v4 | 2017-03-17 | French | Compare |
v3 | 2017-03-17 | English | Compare |
v2 | 2017-03-14 | French | Compare |
v1 | 2017-03-14 | English | Compare |
Showing 1 to 14 of 14